Recon: AbbVie Plans New San Francisco R&D Hub; Merrimack to Cut 60% of Staff – Regulatory Focus


Regulatory Focus

Recon: AbbVie Plans New San Francisco R&D Hub; Merrimack to Cut 60% of Staff
Regulatory Focus
… Endo targets 2020 for launch of cellulite treatment (Reuters); Superbugs pose a dangerous, $65 billion threat to the US health-care system (CNBC); Genentech sues indicted ex-employees and biosim maker over trade secrets theft (Fierce) (BioCentury

Read more: www.raps.org

About the Author AdelinaDuh

Leave a Comment: